ACBC

Discontinued Product

0258 has been discontinued.

View all NMDA Receptors products.
说明: NMDA antagonist; acts at glycine site
化学名: 1-Aminocyclobutane-1-carboxylic acid
说明书
引用文献
评论
文献 (5)

生物活性 for ACBC

ACBC is a NMDA receptor partial agonist, acting at the glycine site of GluN1 (formally NR1).

Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.

技术数据 for ACBC

分子量 115.13
公式 C5H9NO2
储存 Store at RT
CAS Number 22264-50-2
PubChem ID 89643
InChI Key FVTVMQPGKVHSEY-UHFFFAOYSA-N
Smiles NC1(CCC1)C(O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for ACBC

分析证书/产品说明书
选择另一批次:

按产品操作查看相关产品

查看全部 NMDA Receptor Antagonists

关键词: ACBC, ACBC supplier, NMDA, antagonists, glycine, site, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic, GluN1, NR1, 0258, Tocris Bioscience

篇 ACBC 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 ACBC 的引用文献。

ACBC 的评论

目前没有该产品的评论。 Be the first to review ACBC and earn rewards!

Have you used ACBC?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells
Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Huntington's Disease Poster

Huntington's Disease Poster

Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.